MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Carcinoma, Ehrlich Tumor

(UMLS:C0007125)

Definition:: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
UMLS ID:: C0007125
MeSH ID:: D002286

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.470.200.200|C04.619.169

Synonym(s)

Carcinoma, Ehrlich Tumor

Ascites tumors

Ehrlich's tumor

ascites tumor

ehrlich tumor carcinoma

Associated Drug(s)

	Name	Reference(s)	Data Source
1	1'-acetoxychavicol acetate	20230805	CTD
2	11-keto-boswellic acid	21056033	CTD
3	2,5-dihydroxybenzoic acid	29885857	CTD
4	Apigenin	28025107	CTD
5	Chloroquine	24751611	CTD
6	Cyclophosphamide	14641813	CTD
7	Diazepam	19782064	CTD
8	Doxorubicin	View details 1962586 6538499 9700580 9840728 10208759 11419959 26969377	CTD
9	Fluorouracil	21056033 28025107 31288002	CTD
10	Ifosfamide	10619376	CTD
11	Lignans	26620693	CTD
12	Luteolin	31288002	CTD
13	Melatonin	10738105	CTD
14	Pyrroles	30543781	CTD
15	RV 538	8086032	CTD
16	Resveratrol	26969377	CTD
17	Rutin	26091902	CTD
18	Sunitinib	24751611	CTD
19	acetone cyanohydrin	20126898	CTD
20	anethole	7549823	CTD
21	caffeic acid phenethyl ester	20433813	CTD
22	cremophor EL	9840728	CTD
23	diphenylantimony diisopropyldithiophosphate	1667268	CTD
24	diphenylantimony diphenyldithiophosphinate	1667268	CTD
25	goniothalamin	25451594	CTD
26	thymoquinone	10619376	CTD
27	ursolic acid	24051192	CTD
28	violacein	20416285	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Carcinoma, Lewis Lung	54.2%
2	Basal cell carcinoma	44.6%
3	Carcinoma, Papillary	44.6%
4	Squamous cell carcinoma	44.6%
5	Carcinoma, Basal Cell	44.6%
6	Adenocarcinoma	38.9%
7	Carcinoma in Situ	38.9%
8	Carcinoma, Transitional Cell	38.9%
9	Carcinoma, Large Cell	38.9%
10	Carcinoma, Small Cell	38.9%
11	Cystadenocarcinoma	37.9%
12	Mucoepidermoid Carcinoma	37.9%
13	Bowen's Disease	34.4%
14	Carcinoma 256, Walker	32.8%
15	Neoplasms, Neuroepithelial	32.5%
16	Gliomatosis cerebri	32.5%
17	Cystadenoma	31.4%
18	Mesothelioma	31.4%
19	Adenoma	30.3%
20	Carcinoma, Lobular	30.1%
21	Adenoid Cystic Carcinoma	29.8%
22	Adenocarcinoma, Clear Cell	29.8%
23	Cholangiocarcinoma	29.8%
24	Cervical Intraepithelial Neoplasia	29.8%
25	Leukemia, Experimental	29.7%
26	Carcinoid Tumor	29.3%
27	Sarcoma, Experimental	26.8%
28	Leukemia L1210	26.7%
29	Leukemia P388	26.7%
30	leukemia	26.4%
31	Neoplasms, Germ Cell and Embryonal	26.4%
32	Germ Cell Cancer	26.4%
33	Melanoma, Experimental	26.4%
34	Choriocarcinoma	25.8%
35	Mammary Neoplasms, Experimental	25.7%
36	Klatskin Tumor	25.3%
37	Hamartoma	25.3%
38	Neoplasms, Hormone-Dependent	25.3%
39	Neoplasms, Multiple Primary	25.3%
40	Paraneoplastic Syndromes	25.3%
41	Precancerous Conditions	25.3%
42	Neoplasms, Second Primary	25.3%
43	Malignant Carcinoid Syndrome	25.3%
44	Neuroectodermal Tumors	25.2%
45	Medulloblastoma	24.9%
46	Sarcoma 180	24.9%
47	Adenoma, Acidophil	24.2%
48	Ganglioneuroma	24.2%
49	Glioma	24.2%
50	Malignant Glioma	24.2%
51	Acanthoma	23.3%
52	Adenofibroma	22.2%
53	Fibroadenoma	22.2%
54	melanoma	21.7%
55	Carcinosarcoma	21.7%
56	Hemangiosarcoma	21.7%
57	lymphangiosarcoma	21.7%
58	Papilloma	21.1%
59	Pseudomyxoma Peritonei	21.1%
60	Papillomatosis	21.1%
61	Adenomatosis, Pulmonary	21.1%
62	Adenomatous Polyps	21.1%
63	Dermoid Cyst	20.3%
64	Astrocytoma	20.1%
65	Ependymoma	20.1%
66	oligodendroglioma	20.1%
67	Ganglioglioma	20.1%
68	gliosarcoma	20.1%
69	Anaplastic astrocytoma	20.1%
70	Anaplastic Oligodendroglioma	20.1%
71	Meningioma	19.8%
72	Carcinoid Heart Disease	19.7%
73	Histiocytic Disorders, Malignant	19.7%
74	Trophoblastic Neoplasms	19%
75	Carcinoma, Pancreatic Ductal	19%
76	Cyst	18.9%
77	Neoplastic Processes	18.9%
78	Neoplastic Syndromes, Hereditary	18.9%
79	Pregnancy Complications, Neoplastic	18.9%
80	Basal Cell Nevus Syndrome	18.3%
81	Chondrosarcoma	18.2%
82	Craniopharyngioma	18.2%
83	leiomyosarcoma	18.2%
84	liposarcoma	18.2%
85	synovial sarcoma	18.2%
86	Neuroectodermal Tumor, Melanotic	18.2%
87	Angiomyolipoma	18.2%
88	Clear Cell Sarcoma of Soft Tissue	18.2%
89	Alveolar Soft Part Sarcoma	18.2%
90	Neuroendocrine Tumors	18.2%
91	Sarcoma, Myeloid	18.2%
92	Glioblastoma	18.1%
93	Neuroblastoma	18.1%
94	Glioblastoma Multiforme	18.1%
95	Neurilemmoma	17.6%
96	Hutchinson's Melanotic Freckle	17.6%
97	Melanoma, Amelanotic	17.6%
98	Multiple Endocrine Neoplasia	17.2%
99	Liver Neoplasms, Experimental	17.2%
100	Leukemia, Plasma Cell	17.2%
101	Carcinoma, Ovarian Epithelial	17.1%
102	Ganglioneuroblastoma	17.1%
103	Ameloblastoma	16.9%
104	Angiokeratoma	16.9%
105	Chordoma	16.9%
106	Hemangioma	16.9%
107	hemangiopericytoma	16.9%
108	Lymphangioma	16.9%
109	Mesenchymoma	16.9%
110	Nevus	16.9%
111	Teratoma	16.9%
112	Hepatoblastoma	16.9%
113	Mixed Tumor, Mullerian	16.9%
114	Germinoma	16.9%
115	Teratocarcinoma	16.9%
116	Angiofibroma	16.9%
117	Sarcoma	16.9%
118	Composite Lymphoma	16.6%
119	Fibrosarcoma	16.5%
120	Osteosarcoma	16.5%
121	Retinoblastoma	16.2%
122	Leukemia, Radiation-Induced	15.9%
123	Lymphoma	15.6%
124	Malignant Fibrous Histiocytoma	15.6%
125	Vipoma	15.4%
126	Adrenocortical carcinoma	15.3%
127	Paraneoplastic Encephalomyelitis	15.2%
128	Abdominal Neoplasms	14.9%
129	Erythroplasia	14.9%
130	Follicular cyst	14.9%
131	Head and Neck Neoplasms	14.9%
132	Mucocele	14.9%
133	Pilonidal Cyst	14.9%
134	Soft Tissue Neoplasms	14.9%
135	Thoracic Neoplasms	14.9%
136	Thyroglossal Cyst	14.9%
137	Synovial Cyst	14.9%
138	Aberrant Crypt Foci	14.9%
139	Neoplasms, Radiation-Induced	14.8%
140	Paraganglioma	14.8%
141	Rhabdomyosarcoma	14.8%
142	Giant Cell Tumor of Bone	14.8%
143	Thymoma	14.7%
144	Nasopharyngeal carcinoma	14.6%
145	Hepatocellular Adenoma	14.4%
146	Gastrinoma	14.2%
147	Glucagonoma	14.2%
148	Dermatofibrosarcoma	13.9%
149	Dermatofibrosarcoma Protuberans	13.9%
150	Renal Cell Carcinoma	13.4%
151	Papillary Renal Cell Carcinoma	13.4%
152	Carcinoma, Endometrioid	13.1%
153	Pheochromocytoma	13.1%
154	Alveolar rhabdomyosarcoma	13.1%
155	Endometrial Stromal Sarcoma	13%
156	Plasmacytoma	12.6%
157	Malignant histiocytosis	12.5%
158	Histiocytic sarcoma	12.5%
159	Phyllodes Tumor	12.2%
160	Dysgerminoma	12.2%
161	Hemangioendothelioma	12.2%
162	Lipoma	12.2%
163	Myoma	12.2%
164	Myxoma	12.2%
165	Neuroma	12.2%
166	Seminoma	12.2%
167	Angiolipoma	12.2%
168	Myelolipoma	12.2%
169	Neoplasms, Bone Tissue	12.2%
170	Neoplasms, Fibrous Tissue	12.2%
171	Smooth Muscle Tumor	12.2%
172	Desmoplastic Small Round Cell Tumor	12.2%
173	Chondroma	12.2%
174	Enchondroma	12.2%
175	Prolactinoma	12.2%
176	Growth Hormone-Secreting Pituitary Adenoma	12.2%
177	Lymphomatoid Granulomatosis	12.1%
178	Tuberous Sclerosis	12.1%
179	Lymphangioleiomyomatosis	12%
180	Neurofibrosarcoma	12%
181	Multiple Endocrine Neoplasia Type 1	11.8%
182	Digestive System Neoplasms	11.7%
183	Endocrine Gland Neoplasms	11.7%
184	Eye Neoplasms	11.7%
185	Nervous System Neoplasms	11.7%
186	Optic Nerve Glioma	11.4%
187	Bone neoplasms	11.3%
188	Leukoplakia	11.3%
189	Lymphocele	11.3%
190	Pancreatic Cyst	11.3%
191	Skin Neoplasms	11.3%
192	Hematologic Neoplasms	11.3%
193	Nephroblastoma	11.2%
194	Barrett Esophagus	11.1%
195	Breast Cyst	11.1%
196	Actinic keratosis	11.1%
197	Mediastinal Cyst	11.1%
198	Neoplasm Invasiveness	11.1%
199	Neoplasm Metastasis	11.1%
200	Neoplasm Recurrence, Local	11.1%
201	Parovarian Cyst	11.1%
202	Pericardial Cyst	11.1%
203	Splenic Neoplasms	11.1%
204	Thymic Cyst	11.1%
205	Carcinogenesis	11.1%
206	Myxoid cyst	11.1%
207	Metastasis	11.1%
208	Acoustic Neuroma	11%
209	insulinoma	11%
210	Hydatidiform Mole	10.5%
211	Parathyroid Neoplasms	10.3%
212	Peritoneal Neoplasms	10.3%
213	Thyroid Neoplasm	10.3%
214	Thyroid carcinoma	10.3%
215	Retroperitoneal Neoplasms	10.1%
216	fibroma	9.9%
217	Fibromatosis	9.9%
218	Osteoblastoma	9.9%
219	Osteoma	9.9%
220	Rhabdomyoma	9.9%
221	Chondromatosis	9.9%
222	Hemangioblastoma	9.9%
223	Lymphoma, Extranodal NK-T-Cell	9.9%
224	Hodgkin Disease	9.9%
225	Lymphoma, Non-Hodgkin	9.9%
226	Adenomatous Polyposis Coli	9.9%
227	Neoplasms, Glandular and Epithelial	9.2%
228	Leukemia, Myelomonocytic, Chronic	9.1%
229	Tracheal Neoplasms	9.1%
230	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	9.1%
231	Leukoplakia, Oral	8.9%
232	Pancreatic Neoplasm	8.9%
233	Paraneoplastic Cerebellar Degeneration	8.8%
234	Fibromatosis, Aggressive	8.8%
235	Fibromatosis, Abdominal	8.8%
236	Corpus Luteum Cyst	8.8%
237	Ovarian Cysts	8.8%
238	Mesoblastic Nephroma	8.6%
239	Carcinoma, Ehrlich Tumor	8.5%
240	Primary amyloidosis	8.3%
241	Neoplasms, Experimental	8%
242	Thyroid Nodule	7.7%
243	Mouth Neoplasms	7.7%
244	Central Nervous System Neoplasms	7.7%
245	Vascular Neoplasms	7.7%
246	Thymus Neoplasms	7.7%
247	Esophageal Neoplasms	7.6%
248	Genital Neoplasms, Female	7.6%
249	Pancreatic Pseudocyst	7.6%
250	Limbic Encephalitis	7.5%
251	Lymphatic Metastasis	7.5%
252	Neoplasms, Unknown Primary	7.5%
253	Leukemic Infiltration	7.5%
254	Breast Neoplasms, Male	7.5%
255	Neoplasm Micrometastasis	7.5%
256	Triple Negative Breast Neoplasms	7.5%
257	Mastocytoma	7.5%
258	Mastocytosis	7.4%
259	Sturge-Weber Syndrome	7.4%
260	Choledochal Cyst	7.4%
261	Mastocytosis, Systemic	7.4%
262	Leukemia, Myeloid, Chronic-Phase	7.4%
263	Leydig Cell Tumor	7.3%
264	granulosa cell tumor	7.3%
265	Gastrointestinal Stromal Tumors	7.3%
266	Hemangioma, Cavernous	7.3%
267	Leukemia, T-Cell	7.2%
268	Leukemia, B-Cell	7.2%
269	Peutz-Jeghers Syndrome	7.2%
270	neurofibroma	7.2%
271	Lymphoma, Follicular	7.2%
272	T-Cell Lymphoma	7.2%
273	Mantle cell lymphoma	7.2%
274	Carcinoma	6.7%
275	Epithelioma	6.7%
276	Lambert-Eaton Myasthenic Syndrome	6.7%
277	Testicular Neoplasms	6.7%
278	Waldenstrom Macroglobulinemia	6.2%
279	Multiple Myeloma	6.2%
280	Adrenal Gland Neoplasms	6.2%
281	Gastrointestinal Neoplasms	6.2%
282	Genital Neoplasms, Male	6.2%
283	Liver neoplasms	6.2%
284	Uveal Neoplasms	6.2%
285	Urologic Neoplasms	6.1%
286	Sebaceous Gland Neoplasms	6%
287	Spinal Neoplasms	6%
288	Bone Marrow Neoplasms	6%
289	Opsoclonus-Myoclonus Syndrome	5.9%
290	Polycystic Ovary Syndrome	5.9%
291	Denys-Drash Syndrome	5.9%
292	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	5.9%
293	Leukemia, Large Granular Lymphocytic	5.9%
294	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	5.9%
295	Lymphoma, T-Cell, Cutaneous	5.8%
296	Lymphoma, AIDS-Related	5.8%
297	Enteropathy-Associated T-Cell Lymphoma	5.8%
298	Primary Effusion Lymphoma	5.8%
299	Meningeal Neoplasms	5.8%
300	Dupuytren Contracture	5.4%
301	Palatal Neoplasms	5.3%
302	Nose Neoplasms	5.3%
303	Myelitis, Transverse	5.3%
304	Urticaria Pigmentosa	5.3%
305	Mycosis Fungoides	5.2%
306	Lymphomatoid Papulosis	5.2%
307	Plasmablastic lymphoma	5.2%
308	Meningeal Carcinomatosis	4.9%
309	Ear Neoplasms	4.8%
310	Eyelid Neoplasms	4.8%
311	Lung Neoplasms	4.8%
312	Pleural Neoplasms	4.8%
313	Pituitary Adenoma	4.7%
314	Pituitary Neoplasms	4.7%
315	Cell Transformation, Viral	4.7%
316	Brain Neoplasms	4.7%
317	Salivary Gland Neoplasms	4.7%
318	Spinal Cord Neoplasms	4.7%
319	Tongue Neoplasms	4.7%
320	Uterine Neoplasms	4.6%
321	Vaginal Neoplasms	4.6%
322	Vulvar Neoplasms	4.6%
323	Uterine Cancer	4.6%
324	Fallopian Tube Neoplasms	4.6%
325	Xeroderma Pigmentosum	4.4%
326	ovarian neoplasm	4.3%
327	Burkitt Lymphoma	4.2%
328	Bronchial Neoplasms	4%
329	Pharyngeal Neoplasms	4%
330	Multiple Pulmonary Nodules	4%
331	Supratentorial Neoplasms	3.9%
332	Central Nervous System Cysts	3.9%
333	Endometrial Neoplasms	3.9%
334	Bile Duct Neoplasms	3.9%
335	gallbladder neoplasm	3.9%
336	Intestinal Neoplasms	3.9%
337	Penile Neoplasms	3.9%
338	Prostatic Neoplasms	3.9%
339	Stomach Neoplasms	3.9%
340	Polycythemia Vera	3.8%
341	Sezary Syndrome	3.7%
342	Brain Stem Neoplasms	3.6%
343	Laryngeal neoplasm	3.5%
344	Choroid Plexus Papilloma	3.4%
345	Hypopharyngeal Neoplasms	3.3%
346	Pleural Effusion, Malignant	3.3%
347	Hypopharyngeal Cancer	3.3%
348	Zollinger-Ellison syndrome	3.3%
349	Bladder Neoplasm	3.3%
350	Kidney Neoplasm	3.3%
351	Ureteral Neoplasms	3.3%
352	Urethral Neoplasms	3.3%
353	Parotid Neoplasms	3.3%
354	Prostatic Neoplasms, Castration-Resistant	3.3%
355	Nelson Syndrome	3.3%
356	Tonsillar Neoplasms	3%
357	Cerebellar Neoplasms	3%
358	Cecal Neoplasms	2.8%
359	Duodenal Neoplasms	2.8%
360	Radicular Cyst	2.6%
361	Appendiceal Neoplasms	2.5%
362	Colonic Neoplasms	2.5%
363	Rectal Neoplasms	2.5%
364	Nasopharyngeal Neoplasms	2.5%
365	Colorectal Neoplasms	2.4%
366	Paranasal Sinus Neoplasms	2.2%
367	Anus Neoplasms	2.1%
368	Sigmoid Neoplasms	2.1%
369	Maxillary Sinus Neoplasms	2%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234